|
2-carboxy-5-methylpyrazine 1,4-dioxide
|
阿昔莫司杂质1
|
2734844-49-4
|
|
Xanomeline Impurity 1
|
呫若美林杂质1
|
174656-58-7
|
|
2-carboxy-5-methylpyrazine 1-oxide
|
阿昔莫司杂质5
|
98502-96-6
|
|
Ural licorice saponin B
|
乌拉尔甘草皂苷B
|
|
|
Vigabatrin Impurity 8
|
氨己烯酸杂质8
|
7529-16-0
|
|
Betahistine Impurity 4
|
倍他司汀杂质4
|
101252-40-8
|
|
Methyl 5-chloropentanoate
|
5-氯戊酸甲酯
|
14273-86-0
|
|
Ethenesulfonic acid methyl ester
|
乙烯基磺甲酯
|
1562-31-8
|
|
Left western impurity S-isomer
|
左西杂质S-异构体
|
163837-48-7
|
|
Vancomycin Impurity L
|
万古霉素杂质L
|
79517-31-0
|
|
Bis(4-sulfobutyl)ether Disodium Salt
|
双-(4-磺丁基)醚二钠盐
|
183278-30-0
|
|
Cefazolin Impurity I
|
头孢唑林杂质I
|
1172998-53-6
|
|
Samidorphan
|
|
852626-89-2
|
|
(S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline
|
替那帕诺中间体
|
1870821-29-6
|
|
2-((5-bromopyrimidin-2-yl)oxy)ethan-1-ol
|
2-[(5-溴-2-嘧啶基)氧基]乙醇
|
1246922-88-2
|
|
Betahistine Impurity 3
|
倍他司汀杂质3
|
19690-13-2
|
|
Lercanidipine Hydrochloridereference substance (crystal form I)
|
盐酸乐卡地平对照品(I晶型)
|
132866-11-6
|
|
Tyloxapol
|
泰洛沙泊
|
25301-02-4
|
|
(+)-Corey Lactone Diol
|
(+)-科立内酯二醇
|
76704-05-7
|
|
Bevantolol Impurity 16
|
贝凡洛尔杂质16
|
14569-61-0
|
|
Faropenem finished product impurity 23
|
法罗培南成品杂质23
|
2357-76-8
|
|
Betahistine Impurity 2
|
倍他司汀杂质2
|
32635-81-7
|
|
Bevantolol Impurity 07
|
贝凡洛尔杂质07
|
63434-21-9
|
|
Vancomycin Impurity A
|
万古霉素杂质A
|
91700-98-0
|
|
Vancomycin Impurity H
|
万古霉素杂质H
|
357396-41-9
|
|
Bilastine Impurity 05
|
比拉斯汀杂质05
|
2767508-98-3
|
|
4-hydroxybutane-1-sulfonic acid
|
4-羟基丁烷-1-磺胺
|
26978-64-3
|
|
Cefoperam (USP Impurity A)
|
头孢托仑(USP杂质A)
|
|
|
Betahistine Impurity 10
|
倍他司汀杂质10
|
54765-14-9
|
|
N - [5- (4-bromophenyl) -6- [2- [(5-bromo-2-pyrimidinyl) oxy] ethoxy] -4-pyrimidinyl] aminosulfonamide
|
N-[5-(4-溴苯基)-6-[2-[(5-溴-2-嘧啶基)氧基]乙氧基]-4-嘧啶基]氨基磺酰胺
|
110-65-7
|
|
Vigabatrin Impurity 1
|
氨己烯酸杂质1
|
60643-86-9
|
|
Celecoxib Impurity 52
|
塞来昔布杂质52
|
1803258-57-2
|
|
Eicosanol
|
二十醇
|
629-96-9
|
|
Betahistine Impurity 9
|
倍他司汀杂质9
|
128225-22-9
|
|
Ornidazole Impurity 17
|
奥硝唑杂质17
|
95881-05-3
|
|
Lorazepam USP Impurity A
|
劳拉西泮USP杂质A
|
2848-96-6
|
|
5-Methylpyrazine-2-carbonitrile
|
阿昔莫司杂质8
|
98006-91-8
|
|
Xanomeline Impurity 3
|
呫若美林杂质3
|
174656-57-6
|
|
2-Pyrazinecarboxamide, 6-methyl-, 4-oxide
|
阿昔莫司杂质11
|
51037-27-5
|
|
(3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-yl acetate
|
3,4-二氟-2-甲氧基苯基-4,5-二甲基-5-三氟甲基四氢呋喃-2-基乙酸酯
|
2875066-46-7
|
|
NEU1131-H reference standard
|
NEU1131-H对照品
|
1644251-59-1
|
|
Acetyl byproduct 2
N - (4-chloro-2-sulfamoylphenyl) acetamide
|
乙酰副产物 2
N-(4-氯-2-氨磺酰基苯基)乙酰胺
|
19185-77-4
|
|
Nicotine Nitrogen Oxide TRC
|
尼古丁氮氧化物TRC
|
|
|
methyl 5-methylpyrazine-2-carboxylate
|
阿昔莫司杂质15
|
41110-32-2
|
|
1-Oxylato-3-carboxypyrazine-1-ium
|
阿昔莫司杂质21
|
874-54-4
|
|
Vancomycin Impurity C
|
万古霉素杂质C
|
82198-76-3
|
|
Tadalafil iMpurity 16
|
他达拉非杂质16
|
951661-82-8
|
|
Macitentan Impurity
|
马西替坦杂质
|
1433875-21-8
|
|
Macitentan Impurity K
|
马西坦坦杂质K
|
2211054-90-7
|
|
Bilastine Impurity 01
|
比拉斯汀杂质01
|
1841081-72-8
|
|
(-)-Corey Lactone Diol
|
(-)-科立内酯二醇
|
32233-40-2
|
|
4-Ethylaniline
|
对乙苯胺
|
589-16-2
|
|
Betahistine Impurity 5
|
倍他司汀杂质5
|
49745-42-8
|
|
Xanomeline Impurity 13
|
呫若美林杂质13
|
131987-69-4
|
|
Faropenem finished product impurity 22
|
法罗培南成品杂质22
|
87024-25-7
|
|
Vigabatrin Impurity 10
|
氨己烯酸杂质10
|
71107-20-5
|
|
Vigabatrin Impurity 7
|
氨己烯酸杂质7
|
27428-45-1
|
|
5-Methylpyrazine-2,3-dicarboxamide
|
阿昔莫司杂质10
|
74290-70-3
|
|
Vancomycin Impurity F
|
万古霉素杂质F
|
2415254-43-0
|
|
Benazepril Hydrochloride EDQM System Applicability Reference Standard
|
盐酸贝那普利EDQM系统适用性对照品
|
86541-74-4
|
|
Methyl 4-[[[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]-2-pyridinecarboxylate
|
4-(2R,3S,4S,5R)-3-(3,4-二氟-2-甲氧基苯基)-4,5-二甲基-5-三氟甲基四氢呋喃-2-甲酰胺基吡啶甲酸甲酯
|
2879218-02-5
|
|
Pyridinium, 5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-3-hydroxy-1-methyl-
|
呫若美林杂质7
|
2414049-88-8
|
|
Intermediate impurity
|
中间体杂质
|
2875066-56-9
|
|
2(5H)-Furanone
|
2(5H)-呋喃酮
|
497-23-4
|
|
Vorapaxar
|
沃拉帕沙中间体3
|
900161-12-8
|
|
Vigabatrin EP Impurity E
|
氨己烯酸EP杂质E
|
1378466-25-1
|
|
Vigabatrin Impurity 15
|
氨己烯酸杂质15
|
68506-86-5
|
|
2-Pyrazinecarboxylic acid, 6-methyl-, 4-oxide
|
阿昔莫司杂质3
|
51037-31-1
|
|
Bevantolol Impurity 10
|
贝凡洛尔杂质10
|
54737-83-6
|
|
2-METHYL-1H-IMIDAZOLE-4,5-DICARBONITRILE
|
阿昔莫司杂质6
|
40056-53-9
|
|
N-((Z)-2-amino-1,2-dicyanoethenyl)acetamide
|
阿昔莫司杂质7
|
65604-69-5
|
|
Betahistine Impurity 11
|
倍他司汀杂质11
|
91029-17-3
|
|
2-methylpyrazine 1-oxide
|
阿昔莫司杂质17
|
31396-35-7
|
|
(+/-)-Corey Lactone Diol
|
(+/-)-科立内酯二醇
|
54423-47-1
|
|
d-Cloprostenol Sodium
|
D-氯前列醇钠
|
62561-03-9
|
|
Vigabatrin Impurity 9
|
氨己烯酸杂质9
|
2324151-81-5
|
|
Vigabatrin Impurity 12
|
氨己烯酸杂质12
|
1824506-31-1
|
|
Vigabatrin Impurity 3
|
氨己烯酸杂质3
|
2512190-67-7
|
|
Betahistine Impurity 6
|
倍他司汀杂质6
|
37445-98-0
|
|
Bilastine Impurity 01
|
比拉斯汀杂质01
|
110963-63-8
|
|
Bilastine Impurity 02
|
比拉斯汀杂质02
|
1181267-36-6
|
|
Betahistine Impurity 8
|
倍他司汀杂质8
|
103-74-2
|
|
5-(methoxycarbonyl)-2-methylpyrazine 1-oxide
|
阿昔莫司杂质18
|
74416-38-9
|
|
3-amino-2,3-dihydroindene-1-one
|
3-氨基茚满-1-酮
|
117291-44-8
|
|
Bevantolol Impurity 05
|
贝凡洛尔杂质05
|
54738-06-6
|
|
Vigabatrin Impurity 13
|
氨己烯酸杂质13
|
21358-47-5
|
|
5-Methyl-2-pyrazinecarboxylic acid
|
阿昔莫司杂质4
|
5521-55-1
|
|
5-Methyl-2,3-pyrazinedicarboxylic acid
|
阿昔莫司杂质16
|
5521-60-8
|
|
6-Methylpyrazine-2-carboxamide
|
阿昔莫司杂质9
|
5521-62-0
|
|
Betahistine Impurity 27
|
倍他司汀杂质27
|
55967-94-7
|
|
Pyrazine, 2-methyl-,1,4-dioxide
|
阿昔莫司杂质2
|
32046-26-7
|
|
D-Cloprostenol
|
D-氯前列醇
|
54276-21-0
|
|
6-methylpyrazine-2-carboxylic acid
|
阿昔莫司杂质12
|
5521-61-9
|
|
Beta-methylpyridine-2-ethanol
|
beta-亚甲基吡啶-2-乙醇
|
58379-60-5
|
|
Alarelin
|
阿拉瑞林
|
79561-22-1
|
|
5-(ethoxycarbonyl)-2-methylpyrazine 1-oxide
|
阿昔莫司杂质22
|
51037-35-5
|
|
Bevantolol Impurity 01
|
贝凡洛尔杂质01
|
2186-24-5
|
|
Bevantolol Impurity 02
|
贝凡洛尔杂质02
|
621-24-9
|
|
Bilastine Impurity 03
|
比拉斯汀杂质03
|
202189-76-2
|
|
Bevantolol Impurity 03
|
贝凡洛尔杂质03
|
42865-04-3
|